Pipeline of anti‐ Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities
出版年份 2021 全文链接
标题
Pipeline of anti‐
Mycobacterium abscessus
small molecules: Repurposable drugs and promising novel chemical entities
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-03-01
DOI
10.1002/med.21798
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synergistic interactions of indole-2-carboxamides and β-lactam antibiotics against Mycobacterium abscessus
- (2020) Clément Raynaud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. NATURE REVIEWS MICROBIOLOGY
- Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model
- (2020) Deepak V. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice
- (2020) Vincent Le Moigne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- State-of-the-art treatment strategies for nontuberculous mycobacteria infections
- (2020) Maria-Carmen Muñoz-Egea et al. EXPERT OPINION ON PHARMACOTHERAPY
- Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo
- (2020) Camron Pearce et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimycobacterial Activity of Laurinterol and Aplysin from Laurencia johnstonii
- (2020) Sara García-Davis et al. Marine Drugs
- Structure‐Based Design and Synthesis of Piperidinol‐Containing Molecules as New Mycobacterium abscessus Inhibitors
- (2020) Jérôme Ruyck et al. ChemistryOpen
- Development of Delpazolid for the Treatment of Tuberculosis
- (2020) Young Lag Cho et al. Applied Sciences-Basel
- AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward Mycobacterium abscessus
- (2020) Shaoyan Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
- (2020) Charles L Daley et al. CLINICAL INFECTIOUS DISEASES
- Efflux Pump Inhibitors against Nontuberculous Mycobacteria
- (2020) Laura Rindi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural Basis for the Inhibition of Mycobacterial MmpL3 by NITD-349 and SPIRO
- (2020) Xiaolin Yang et al. JOURNAL OF MOLECULAR BIOLOGY
- Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification
- (2020) Sherine E Thomas et al. NUCLEIC ACIDS RESEARCH
- MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
- (2020) Jigar P. Sethiya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Etamycin as a Novel Mycobacterium abscessus Inhibitor
- (2020) Bui Thi Bich Hanh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus
- (2019) Mary P. Choules et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Indole-2-carboxamides are Active Against an Acute Mycobacterium abscessus Infected Mouse Model
- (2019) Amit N. Pandya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of the new β-lactamase inhibitors relebactam and vaborbactam in combination with β-lactams against Mycobacterium abscessus complex clinical isolates
- (2019) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis of Long-Chain β-Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria
- (2019) Pierre Santucci et al. ChemMedChem
- Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus
- (2019) Júlia S. Vianna et al. Journal of Global Antimicrobial Resistance
- Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
- (2019) Wei Li et al. ACS Infectious Diseases
- Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro
- (2019) R. Pandey et al. mBio
- Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound
- (2019) Pamela K. Garcia et al. PLoS One
- Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria
- (2019) Swetarka Das et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Eugenol and derivatives activity against Mycobacterium tuberculosis, nontuberculous mycobacteria and other bacteria
- (2019) Aryadne L de Almeida et al. Future Microbiology
- Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
- (2019) Nakwon Kwak et al. EUROPEAN RESPIRATORY JOURNAL
- Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
- (2019) Bing Zhang et al. CELL
- Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro
- (2019) Elizabeth Story-Roller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex
- (2019) Aristine Cheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activities of omadacycline against rapidly growing mycobacteria
- (2019) Carolyn Shoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Antimycobacterial Compounds Suppress NAD Biogenesis by Targeting a Unique Pocket of NaMN Adenylyltransferase
- (2019) Andrei L. Osterman et al. ACS Chemical Biology
- Synergistic efficacy of β-lactam combinations against Mycobacterium abscessus pulmonary infection in mice.
- (2019) Elizabeth Story-Roller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment
- (2019) David Tenero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
- (2019) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease
- (2019) Simon F.K. Lee et al. CURRENT OPINION IN PULMONARY MEDICINE
- Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection
- (2019) Lea Bentur et al. Journal of Cystic Fibrosis
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Auranofin activity exposes thioredoxin reductase as a viable drug target in Mycobacterium abscessus
- (2019) Mike Marvin Ruth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the In Vitro Activity of β-Lactam Antibiotics Against Mycobacterium abscessus Complex Clinical Isolates
- (2019) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Improved activity of bedaquiline by verapamil against Mycobacterium abscessus in vitro and in macrophages
- (2019) Albertus Viljoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The TetR-family transcription factor MAB_2299c regulates the expression of two distinct MmpS-MmpL efflux pumps involved in cross-resistance to clofazimine and bedaquiline in Mycobacterium abscessus
- (2019) Ana Victoria Gutiérrez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 1H-benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis
- (2019) Małgorzata Korycka-Machała et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
- (2019) Marissa Lindman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
- (2019) Dae Hun Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Repositioning rifamycins for Mycobacterium abscessus lung disease
- (2019) Uday S. Ganapathy et al. Expert Opinion on Drug Discovery
- Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
- (2019) Hannelore I Bax et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches
- (2019) Andrew J. Whitehouse et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of Mycobacterium abscessus
- (2019) Abdeldjalil Madani et al. ACS Infectious Diseases
- Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance
- (2019) John T. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus
- (2019) Ivy B. Ramis et al. TUBERCULOSIS
- Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity
- (2019) Manjunatha M. R et al. ACS Medicinal Chemistry Letters
- Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease
- (2019) Jianhui Chen et al. Frontiers in Microbiology
- Rifabutin is active against Mycobacterium abscessus in mice
- (2019) Thomas Dick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3
- (2019) Christian Dupont et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in Mycobacterium abscessus
- (2019) Ria Sorayah et al. ACS Infectious Diseases
- 1360. Disseminated Mycobacterium abscessus Infections in Patients with Neutralizing Anti-interferon-gamma Autoantibodies Treated with Rifabutin-based Combination Regimens
- (2019) Aristine Cheng et al. Open Forum Infectious Diseases
- In Vitro Susceptibility Testing of GSK656 against Mycobacterium Species
- (2019) Wenzhu Dong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity
- (2019) Mustafa Mert Sirim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
- (2019) Mike Marvin Ruth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill
- (2019) Tawanda Gumbo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Plakinamine P, A Steroidal Alkaloid with Bactericidal Activity against Mycobacterium tuberculosis
- (2019) Carolina Rodrigues Felix et al. Marine Drugs
- Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection
- (2019) Tae Ho Kim et al. MOLECULES
- Mycobacterial HflX is a ribosome splitting factor that mediates antibiotic resistance
- (2019) Paulami Rudra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus
- (2019) Clément Raynaud et al. ACS Infectious Diseases
- Rifabutin acts in synergy and is bactericidal with frontline Mycobacterium abscessus antibiotics clarithromycin and tigecycline, suggesting a potent treatment combination
- (2018) Mark Pryjma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effective treatment of the Mycobacterium avium subsp hominissuis and Mycobacterium abscessus sp. infections in macrophages, biofilm and in mice using Liposomal ciprofloxacin
- (2018) James D. Blanchard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and intracellular activity of imipenem combined to rifabutin and avibactam against Mycobacterium abscessus
- (2018) Eva Le Run et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis
- (2018) Chao Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter
- (2018) Huiqing Zheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus
- (2018) Bing Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus
- (2018) Rashmi Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis of Avibactam Derivatives and Activity on β-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria
- (2018) Zainab Edoo et al. CHEMISTRY-A EUROPEAN JOURNAL
- In vitro activity of tedizolid against the Mycobacterium abscessus complex
- (2018) Fabrice Compain et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- NTM drug discovery: status, gaps and the way forward
- (2018) Mu-Lu Wu et al. DRUG DISCOVERY TODAY
- 1 H -Benzo[ d ]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity
- (2018) Fernanda Souza Macchi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases
- (2018) Phuong Chi Nguyen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Benzoboroxoles: Synthesis and applications in medicinal chemistry
- (2018) Gautam R. Mereddy et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Antimicrobial and Efflux Inhibitor Activity of Usnic Acid Against Mycobacterium abscessus
- (2018) Ivy Ramis et al. PLANTA MEDICA
- Pathogen Box screening for hit identification against Mycobacterium abscessus
- (2018) Jinsun Jeong et al. PLoS One
- Mechanistic and Structural Insights Into the Unique TetR-Dependent Regulation of a Drug Efflux Pump in Mycobacterium abscessus
- (2018) Matthias Richard et al. Frontiers in Microbiology
- Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
- (2018) Dinah B. Aziz et al. Frontiers in Microbiology
- MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
- (2018) Wei Li et al. Frontiers in Microbiology
- Challenges of NTM Drug Development
- (2018) Joseph O. Falkinham Frontiers in Microbiology
- Discovery of benzothiazole amides as potent antimycobacterial agents
- (2018) James Graham et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Treatment of Mycobacterium abscessus Complex
- (2018) Kevin Winthrop et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates—An in vitro Characterization Study
- (2018) Ying Wei Tang et al. Frontiers in Microbiology
- Mycobacterial Cell Wall Synthesis Inhibitors Cause Lethal ATP Burst
- (2018) Annanya Shetty et al. Frontiers in Microbiology
- The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance
- (2018) Sakshi Luthra et al. Frontiers in Microbiology
- Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
- (2018) Mary A. De Groote et al. Frontiers in Microbiology
- In Vitro Susceptibility Testing of Bedaquiline Against Mycobacterium abscessus Complex
- (2018) Barbara A. Brown-Elliott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ
- (2018) Andrew M. Hogan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria
- (2018) Mike Marvin Ruth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria
- (2018) Bei Shi Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer
- (2018) Nicole Scherr et al. Nature Communications
- In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics
- (2018) Yaojie Shen et al. Biomed Research International
- Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption
- (2018) Annanya Shetty et al. Frontiers in Microbiology
- The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model
- (2018) Michal Meir et al. Antimicrobial Resistance and Infection Control
- Prevalence of nontuberculous mycobacteria and high efficacy of D-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus
- (2018) Azar Dokht Khosravi et al. Infection and Drug Resistance
- Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections
- (2017) Silvan Vesenbeckh et al. EUROPEAN RESPIRATORY JOURNAL
- Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus
- (2017) Amit Kaushik et al. Future Microbiology
- Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes
- (2017) Pouya Hassandarvish et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria
- (2017) Barbara A. Brown-Elliott et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria
- (2017) Diana A. Aguilar-Ayala et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections
- (2017) Alan P. Kozikowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
- (2017) Xianfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
- (2017) Charles S Haworth et al. THORAX
- Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
- (2017) Dirk Bald et al. mBio
- Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens
- (2017) Trudy H. Grossman et al. mSphere
- Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche
- (2017) Sarah A McGuffin et al. Open Forum Infectious Diseases
- Biofilm Formation byMycobacterium abscessusin a Lung Cavity
- (2016) Kevin P. Fennelly et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
- (2016) Andrés Palencia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment
- (2016) Faiza Mougari et al. Expert Review of Anti-Infective Therapy
- Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov.
- (2016) Enrico Tortoli et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Bactericidal and intracellular activity of β-lactams againstMycobacterium abscessus
- (2016) Anne-Laure Lefebvre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Intrinsic rifamycin resistance ofMycobacterium abscessusis mediated by ADP-ribosyltransferase MAB_0591
- (2016) Anna Rominski et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence ofmmpT5Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease
- (2016) David C. Alexander et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria
- (2016) Isha Soni et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection
- (2016) Jozef Stec et al. JOURNAL OF MEDICINAL CHEMISTRY
- A new piperidinol derivative targeting mycolic acid transport inMycobacterium abscessus
- (2016) Christian Dupont et al. MOLECULAR MICROBIOLOGY
- Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus
- (2015) Vincent Dubée et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
- (2015) Andrés Obregón-Henao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus
- (2015) Maher Y. Abdalla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure–activity relationship
- (2015) Katarzyna Gobis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
- (2015) Julie V. Philley et al. CHEST
- Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic
- (2015) Steven D. Burdette et al. CLINICAL INFECTIOUS DISEASES
- Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues
- (2015) Katarzyna Gobis et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates
- (2015) Zsuzsa Baranyai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chronic pulmonary disease withMycobacterium abscessuscomplex is a biofilm infection
- (2015) Tavs Qvist et al. EUROPEAN RESPIRATORY JOURNAL
- A new dehydratase conferring innate resistance to thiacetazone and intra-amoebal survival ofMycobacterium smegmatis
- (2015) Séverine Carrère-Kremer et al. MOLECULAR MICROBIOLOGY
- Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum
- (2015) Graham Devereux et al. EBioMedicine
- In Vitro Tedizolid Minimum Inhibitory Concentration (MIC) Against Clinical Isolates of Mycobacterium abscessus
- (2015) Claudia Taramona-Espinoza et al. Open Forum Infectious Diseases
- Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery
- (2015) María Jose Rebollo-Lopez et al. PLoS One
- Nontuberculous Mycobacteria among Patients with Cystic Fibrosis in the United States. Screening Practices and Environmental Risk
- (2014) Jennifer Adjemian et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
- (2014) Christopher P. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus
- (2014) Florian P. Maurer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Metallodrugs in Medicinal Inorganic Chemistry
- (2014) Katja Dralle Mjos et al. CHEMICAL REVIEWS
- Mycolic Acids: Structures, Biosynthesis, and Beyond
- (2014) Hedia Marrakchi et al. CHEMISTRY & BIOLOGY
- Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection
- (2014) Ky V. Hoang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
- (2014) R. J. Wallace et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In VitroActivity of Flomoxef Against Rapidly Growing Mycobacteria
- (2014) Moan-Shane Tsai et al. JOURNAL OF CHEMOTHERAPY
- Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability
- (2014) Anne-Laure Grillot et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis
- (2014) Marylee V. Worley et al. PHARMACOTHERAPY
- Covalent Modification of the Mycobacterium tuberculosis FAS-II Dehydratase by Isoxyl and Thiacetazone
- (2014) Anna E. Grzegorzewicz et al. ACS Infectious Diseases
- Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties
- (2013) E. Jeffrey North et al. BIOORGANIC & MEDICINAL CHEMISTRY
- DprE1, a new taxonomic marker in mycobacteria
- (2013) Maria Loreto Incandela et al. FEMS MICROBIOLOGY LETTERS
- Progress in targeting cell envelope biogenesis inMycobacterium tuberculosis
- (2013) Mary Jackson et al. Future Microbiology
- Characterization of broad-spectrum Mycobacterium abscessus class A -lactamase
- (2013) D. Soroka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
- (2013) Isabelle Lerat et al. JOURNAL OF INFECTIOUS DISEASES
- Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
- (2013) Oluseye K. Onajole et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents
- (2013) Ravinder Reddy Kondreddi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- The Detection and Sequencing of a Broad-Host-Range Conjugative IncP-1β Plasmid in an Epidemic Strain of Mycobacterium abscessus subsp. bolletii
- (2013) Sylvia Cardoso Leão et al. PLoS One
- Antimicrobial Susceptibility of Standard Strains of Nontuberculous Mycobacteria by Microplate Alamar Blue Assay
- (2013) Guilian Li et al. PLoS One
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- In VitroActivity of TP-271 against Mycobacterium abscessus, Mycobacterium fortuitum, and Nocardia Species
- (2012) Michael Cynamon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
- (2012) B. A. Brown-Elliott et al. CLINICAL MICROBIOLOGY REVIEWS
- A Common Mechanism of Inhibition of theMycobacterium tuberculosisMycolic Acid Biosynthetic Pathway by Isoxyl and Thiacetazone
- (2012) Anna E. Grzegorzewicz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
- (2012) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone inMycobacterium tuberculosisandMycobacterium kansasii
- (2012) Juan M. Belardinelli et al. MOLECULAR MICROBIOLOGY
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
- (2012) Anna E Grzegorzewicz et al. Nature Chemical Biology
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
- (2011) Ken Coleman CURRENT OPINION IN MICROBIOLOGY
- Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae
- (2011) S. Chopra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae
- (2011) T. Mukherjee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clofazimine: current status and future prospects
- (2011) M. C. Cholo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro and In Vivo Activities of LCB01-0371, a New Oxazolidinone
- (2010) J.-W. Jeong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activities of DC-159a, a Novel Fluoroquinolone, against Mycobacterium Species
- (2010) A. Disratthakit et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria
- (2010) T. Dubuisson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
- (2010) Charles R. Esther et al. Journal of Cystic Fibrosis
- The Arabinosyltransferase EmbC Is Inhibited by Ethambutol in Mycobacterium tuberculosis
- (2009) R. Goude et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France
- (2009) A.-L. Roux et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus
- (2009) Fabienne Ripoll et al. PLoS One
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships
- (2008) Paul S. Charifson et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now